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Bronchoalveolar lavage (BAL) studies in 20 patients at Bhopal, 1.3 -+ 0.4 yr and 2.7 f 0.6 yr after toxic gas 
exposure had revealed that the lower respiratory tract inflammation had progressed from initial macrophage 
alveolitis to macrophage-neutrophilic alveolitis. The interval between the two lavages was 1.4 Z+Z 0.6 yr. BAL 
studies in a new group of 24 patients 5.1 f 1.0 yr after exposure had confirmed chronic inflammation of the 
lower respiratory tract as evidenced by macrophage-neutrophilic alveolitis in these subjects as well. Clinical, 
radiographic and pulmonary function abnormalities were persistent in a proportion of subjects in both 
groups. 
Fibronectin (FN) levels were estimated in BAL fluid in 41 patients. Elevated FN levels were seen in 12 
(29.3%) subjects and nine of these 12 had radiographic abnormalities. Severely exposed subjects (n=30) had 
significantly higher BAL fibronectin levels compared to normal subjects and mild/moderately exposed 
subjects. Repeat FN estimations in BAL samples from 10 patients had revealed that five had abnormally high 
FN including three who had high FN on both occasions. The number of patients showing abnormal decline 
in pulmonary function was higher in patients with elevated FN than in patients with normal FN. 
Thus, persisting clinical, roentgenographic and ventilatory abnormalities, as well as macrophage- 
neutrophilic alveolitis along with abnormally elevated FN levels in a proportion of subjects, suggest the 
possibility that lung fibrosis can occur in subjects exposed to toxic gas at Bhopal. 
Introduction 
Bronchoalveolar lavage (BAL) studies in toxic 
gas exposed subjects 1.5 f 0.6 yr after exposure 
(1985-1987) had revealed that there was a subclinical 
alveolitis characterized by accumulation of macro- 
phages in the lower respiratory tract, especially in 
severely exposed subjects (1). It was not certain from 
this study whether the inflammatory cells recovered 
from the lower respiratory tract were activated; and if 
so, is there any evidence of release of markers of 
activity such as fibronectin (FN) by these cells into 
the lavage fluid? It is possible that the macrophage 
alveolitis may have spontaneous remission, as it had 
been shown in pneumoconiosis that initial macro- 
phage alveolitis did not necessarily lead to interstitial 
fibrosis (2). However, there is also a possibility that 
the cells comprising alveolitis may release toxic 
mediators (3) resulting in injury and fibrosis to lung 
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parenchyma. A study was, therefore, planned to 
investigate the fate of alveolitis in patients from the 
first study (1) by relavaging them 2.7 + 0.6 yr (1987- 
1989) after exposure and also to evaluate changes in 
the lower respiratory tract in a new group of patients 
5.1 f l.Oyr (1988-1991) after exposure. The study 
was further utilized to investigate the presence of 
markers of activity from inflammatory cells by 
estimating FN concentrations in BAL fluid. 
Subjects and Methods 
This study involving 44 patients was done 2-7 yr 
(1987-1991) after exposure to the toxic gas. All 
studies were carried out under protocols approved by 
the Indian Council of Medical Research, New Delhi. 
Informed consent was obtained from each subject 
after explaining the procedure in local language. 
SUBJECTS 
Twenty out of 36 patients studied initially during 
1985-1987 (1) were willing for relavage studies. The 
first lavage in these 20 patients was carried out 
(: 1995 W. B. Saunders Company Ltd 
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1.3 f 0.4 yr after exposure. Relavages were carried 
out during 1987-1989 i.e. 2.7 * 0.6 yr after exposure 
and they are designated as Group 1 subjects. The 
interval between the two lavages was 1.4 f 0.6 yr. A 
new group of 24 patients was also studied during 
1988-1991 i.e. 5.1 Z!Z l.Oyr after exposure and is 
classified as Group 2. The selection criteria for Group 
2 patients were similar to those for the initial study 
(1). Briefly, all patients were residents of an area near 
the Union Carbide factory (within 5 km) and were 
exposed to the toxic gas on the night of December 
2-3, 1984. All had respiratory and ophthalmic symp- 
toms on the day of exposure and continued to have 
respiratory symptoms at the time of evaluation. Main 
symptoms were cough, exertional dyspnoea and 
chest pain. None of them had any previous cardio- 
respiratory disease as assessed intensively by history, 
physical examination and skiagram chest. Patients 
with the slightest doubt of pre-existing lung disease 
were excluded from the study. 
CONTROL SUBJECTS 
Seventeen non-smoking individuals (age 
28.8 f 8.5 yr) were studied as control subjects for 
comparison with BAL cellular profile. They were 
unexposed to the toxic gas and were residents of 
Madras city. For comparison of BAL fluid fibronec- 
tin, 10 non-smoking, normal subjects, not exposed to 
the gas and residing at Delhi were evaluated. None of 
the control subjects had respiratory symptoms or 
abnormal physical findings and all had normal chest 
radiographs. Pulmonary function measurements in 
control subjects were similar to those of predicted 
values (4). None of the normal subjects was on any 
medication. 
PRE-LAVAGE ASSESSMENT AND INVESTIGATIONS 
Pre-lavage assessment and investigations of each 
patient included detailed history, physical examina- 
tion, a full-plate PA chest roentgenogram, a 12 lead 
electrocardiogram, total and differential leucocyte 
count in the peripheral blood and pulmonary func- 
tion tests such as FVC, FEV, and FEV,/FVC% 
(using Transfer Test Model C, PK Morgan Pvt Ltd, 
Chatham, U.K.). Patients with pre-existing lung 
diseases were excluded from the study. 
BRONCHOALVEOLAR LAVAGE 
Bronchoscopy and bronchoalveolar lavages (BAL) 
were carried out as an outpatient procedure at 
Hamidia Hospital, Bhopal, as previously described 
(1). In brief, the flexible fibre optic bronchoscope was 
passed either transnasally or transorally and the 
lavages were done from three subsegments viz. right 
middle lobe, lingula and left lower lobe. BAL was 
performed with 300 ml sterile 0.9% saline at room 
temperature. One hundred millilitres of sterile saline 
in five 20 ml aliquots was infused through the fibre 
optic bronchoscope into each of the three lobes in the 
lower respiratory tract. After each aliquot was 
infused, the cells and lavage fluids were recovered by 
gentle suction using SO-100 mmH,O negative press- 
ure with a clinical suction apparatus and collected 
in the specimen traps (Sherwood Medical, Ireland). 
The cells recovered by lavage were counted on a 
haemocytometer, using the unconcentrated lavage 
fluid (5) and expressed as cells dl~ ’ of recovered 
fluid. The lavage cell differentials were determined 
using filtration method (5). Using oil immersion of a 
microscope, alveolar macrophages, lymphocytes, 
neutrophils and eosinophils were identified and 400 
cells were counted from each preparation for deriving 
the differentials by two independent observers and 
recorded independently. Both observers agreed to 
within 5% of all lavages and the mean value was used 
for analysis. Epithelial cells counted were always less 
than 5%. Absolute numbers of different types of 
cells were derived from total cells times differential 
percentages. 
FIBRONECTIN ESTIMATION 
Fibronectin (FN) and albumin in BAL fluid were 
estimated in 41 patients including 31 patients from 
the initial study (1). Thirty patients had severe expo- 
sure and 11 had mild/moderate exposure and the 
severity of exposure was determined as per previously 
defined criteria (1). Ten severely exposed patients and 
one mild/moderately exposed patient were smokers. 
Ten patients from the initial study had two FN 
estimations from two lavages on different occasions. 
The interval between the two lavages was 
1.6 & 0.7 yr. Fibronectin was measured by simple 
radialimmunodiffusion (6) with immunodiffusion 
plates (LC Partigen, Behring Diagnostics, Germany). 
Albumin estimation was done by spectrophotometric 
method (6). FN in BAL fluid was expressed as 
w3 w ~ ’ albumin. 
ANALYSIS 
Statistical analysis was done using Mann-Whitney 
U-test for independent groups and Wilcoxon Signed 
Rank-test for paired observations. 
Fibronectin values more than two standard devi- 
ations above the mean of normal subjects (i.e. 
llougmgg’ albumin) were classified as abnor- 
mally high. Odds ratio was calculated to find the 
relative risk of severity of exposure with elevated FN 
levels. If either FVC or FEV, decreased by more than 
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10% during the second lavage, patients were charac- 
terized as ‘deteriorated’. If none of the parameters 
decreased by more than 10% or any parameter 
increased by more than lo%, they were classified as 
‘no change or imprcvement’ (7). 
Results 
GROUP I PATIENTS 
All patients in this group (n=20) were males. The 
mean age was 38.5 + 9 yr. Three patients continued 
to smoke though with reduced intensity, despite 
repeated medical advice to quit smoking. Respiratory 
symptoms such as cough, exertional dyspnoea and 
chest pain were persisting in all patients at the time of 
the second lavage. Four patients had raleslrhonchi at 
initial study. Signs persisted in three and disappeared 
in one. However, three developed fresh signs, making 
a total of six patients with rales/rhonchi at the time of 
the second lavage. Radiographic abnormalities of l/O 
to 2/l (ILO, 1980 classification) (8) were observed in 
nine out of 20 patients. Although there was no 
significant difference in pulmonary function measure- 
ments (FVC and FEV,) between the first and second 
lavages, these continued to be significantly lower 
than the normal predicted values (9,10) during the 
second lavage (Table 1). 
BAL results during the first and second lavages in 
Group 1 patients are shown in Table 2. Total inflam- 
matory cells (P=O.O04) and absolute (total) number 
of alveolar macrophages (P=O.O03) were significantly 
higher in patients compared to normal subjects dur- 
ing the first lavage, despite significantly lower fluid 
recovery (normal subjects YS. Group 1 patients; 
60.1 f 7.0 ml, 44.6 & 13.2 ml, P=O.OOS). During the 
second lavage, the total inflammatory cells (P=O.O04) 
and total macrophages (P=O.O02) continued to be 
significantly higher than normal subjects. In addition, 
there was a significant rise in the neutrophil propor- 
tion (P=O.O2) and total neutrophils (P=O.O3). In 
comparison with results of the first lavage, a signifi- 
cant rise in neutrophil percentage (P=O.O2) and total 
neutrophils (P=O.O4) was also seen during the second 
lavage. There was no significant difference in the fluid 
recovery between the first and the second lavage 
(44.6 =t 13.2 vs. 48.3 zt 12.4, I-0.2). 
GROUP Z PATIENTS 
Of the 24 patients in this group, six were females 
and two males were smokers. The mean age was 
34.1 & 9.5 yr. All patients had persistent respiratory 
symptoms such as cough, dyspnoea on exertion and 
chest pain and three had rhonchi. Radiographic 
abnormalities of l/O to 2/2 were observed in 15 out of 
T&e I Pulmonary function results 
Observed Predicted % Predicted 
Group I (n=20) 
(a) First BAL 
FVC: 
FEV,: 
FEV,/FVC’% 
(b) Second BAI 
FVC: 
FEV,: 
FEV ,/FVC% 
Group 2 (n=24) 
FVC: 
FEV, 
FEV , /FVC’%, 
Control subjects 
(n= 17) 
FVC: 
FEV,: 
FEV,/FVC% 
3,08* 3.83 
*o 82 i 0.43 
2,45+ 3.06 
f 0.77 f 0.34 
79.2 
f 11.5 
3.19* 3.80 
f 0.70 f 0.45 
2,40* 3.06 
f 0.73 f 0.34 
74.7 
zt 13.2 
3,12** 3.53 
i 0.92 f 0.67 
2.46*** 2.82 
zk 0.84 i 0.53 
80.5 
* 13.3 
3.08 3.16 
f 0.59 f 0.52 
2.70 2.81 
f 0.59 f 0.54 
87.1 
* 7.3 
80.4 
f 19.7 
80.0 
f 23.0 
83.3 
f 14.6 
78.4 
f 20.4 
87.5 
f 18.0 
87.1 
i 25.1 
97.3 
f 12.9 
95.2 
f 14.8 
Group I: Patients with first and second BAL. 
Group 2: New series of patients with BAL. 
P value, *<O.OOl, **<O.Ol, ***<0.05. 
24 patients. FVC and FEV, were significantly lower 
in this group as well, as compared to the normal 
predicted values (9,lO) (Table 1). 
The mean values of total inflammatory cells 
(P=O.O4), total alveolar macrophages (P=O.O3), neu- 
trophils percentage (P=O.O09) and total neutrophils 
(P=O.O07) were significantly higher in this group of 
patients compared to normal subjects (Table 2). The 
mean fluid recovery was similar in normal subjects 
and patients (normal 60.1 & 7 ml vs. 56.0 & 8.8 ml, 
P=O.l). 
F’IBRONECTIN LEVELS 
The mean FN level in 10 non-smoking normal 
subjects was 6.31 f 1.83 ug mg ~ ’ albumin. The 
mean FN level in severely exposed patients (n = 30) 
13.2 f 11.1 ug mg - ’ albumin, was significantly 
higher (P=O.O4) compared to normal subjects and 
this was true when only non-smokers (n=20) were 
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Table 2 Bronchoalveolar lavage results 
Normal 
subjects 
(n= 17) 
Group 1 
First lavage Second lavage Group 2 
(n=20) (n=20) (n=24) 
Total cells 
x lo6 dl~ ’ 
Macrophages 
‘4 
x lObdIm’ 
Lymphocytes 
‘4 
x 106dlm’ 
Neutrophils 
‘%, 
x 106dlm’ 
Eosinophils 
‘VI, 
x 106dl-’ 
‘%t Recovery 
15.8 28.0* 31.6* 26.4t 
f 6.1 f 15.2 f 20.3 i 20.2 
83.9 88.3 87.7 89.4 
f 6.4 i 8.0 f 7.0 f 11.0 
13.2 25.3* 27.6* 24.17 
f 5.6 f 15.3 i 17.8 f 19.9 
14.4 10.2 8.0* 7.1t 
f 6.4 i 7.6 f 5.1 f 10.0 
2.4 2.4 2.6 1.5 
i 1.5 i 2.0 f 3.3 * 2.5 
0.7 1.1 3+** 2.lf 
+ 0.8 f 1.4 f4.5 f 1.8 
0.1 0.3 1,2** 0.5$ 
f 0.1 zko.3 i 2.1 f 0.6 
1 .o 0.4 0.8 1.4 
f 1.1 * 1.8 LL 1.6 f 2.6 
0.1 0.1 0.2 0.3 
f 0.1 io.4 f 0.4 f 0.5 
60.1 44.6* 48.3* 56.0 
f 7.0 f 13.2 GY 12.4 * 8.8 
P values 
Group 1 
*<O.Ol as compared to normal subjects. 
**co.05 as compared to normal subjects and 1st lavage. 
Group 2 
tc0.05, $<O.Ol as compared to normal subjects. 
considered (P=O.O3). In mild/moderately exposed 
patients (n= 1 l), the mean FN level, 7.0 f 2.9 
lgmg-’ albumin was similar to normal subjects 
(Table 3). Twelve out of 41 patients (29.3%) had 
elevated FN levels in BAL fluid. Of these 12 patients, 
11 had severe exposure and one had moderate 
exposure. Severely exposed subjects had six times 
(odds ratio = 5.8) higher risk of having increased FN 
levels than mild/moderately exposed subjects. Radio- 
graphic abnormalities of l/O or greater were observed 
in 23 out of 41 patients. The mean FN level 
(12.9It ll.Ougmgg albumin) in the radiologically 
abnormal group (n=23) had shown a trend towards 
higher values compared to the mean FN values 
(9.9 f 8.0 pg mg ~ ’ albumin) in the radiologically 
normal group (P=O.OS). Radiological abnormalities 
were seen in nine of 12 patients with elevated FN 
levels and 14 of 29 with normal FN levels. 
In 10 patients who had FN estimations in two 
lavage samples at different time points, there was no 
significant difference on FN levels (first lavage 
13.0 f 9.6 pg mg - i albumin vs. second lavage 
13.3fll.Sugmgg albumin, DO.2) (Table 3). Of 
these 10, four had elevated levels during the first 
lavage and three continued to have elevated levels 
during the second lavage. One patient who had 
normal FN during the first lavage had an elevated 
level during the second lavage. Another subject with 
elevated levels during the first lavage had shown a 
reduction to normal values during the second lavage. 
Thus, five subjects had elevated FN levels at any one 
occasion. Of the five patients who had elevated FN 
levels, three had functional deterioration and two 
had no change. All were non-smokers. On the other 
hand, of the five subjects who had normal FN levels 
on both occasions, two deteriorated and one was a 
smoker; one improved and two had no change. Thus, 
three of five subjects who had elevated FN at any one 
occasion had a decline in pulmonary function, 
whereas only one of four subjects (excluding smoker) 
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with normal FN on both occasions had a decline in 
pulmonary function. 
Discussion 
The observation that the lower respiratory tract 
inflammation has progressed from macrophage 
alveolitis to macrophage-neutrophilic alveolitis 
2.7 f 0.6 yr after toxic gas exposure and the finding 
of macrophage-neutrophilic alveolitis in a new cohort 
of patients during 1988-1991 (5.1 f I.0 yr after expo- 
sure) suggests that chronic inflammation of the lower 
respiratory tract is a feature of toxic gas-induced lung 
disease. The fact that alveolar macrophages and 
neutrophils are capable of promoting lung injury and 
fibrosis (11) suggests the possibility that inhaled toxic 
gas may produce permanent damage to pulmonary 
parenchyma. Abnormal accumulation of macro- 
phages with or without neutrophils has been 
described in various chronic lung diseases (12-14) 
and also in experimental studies in animals exposed 
to asbestos fibres (15,16). It has also been shown in 
idiopathic pulmonary fibrosis that activated alveolar 
macrophages can produce neutrophil chemo- 
attractants (17,lS). Therefore, we believe that the 
progression of initial macrophage alveolitis to 
macrophage-neutrophilic alveolitis represents the 
stages in the evolution of ‘toxic gas induced lung 
disease’. Thus, the persistence of clinical, radiological 
and pulmonary function abnormalities in this study 
as well as in previous studies (19-21) may be due 
to the consequences of macrophage-neutrophilic 
alveolitis. 
Abnormally elevated FN levels in BAL fluid were 
observed in nearly 30% of patients in this study and a 
higher proportion of severely exposed subjects had 
elevated FN levels compared to mildly/moderately 
exposed. Elevated levels of FN in BAL fluid had been 
described in interstitial lung diseases such as sarcoid- 
osis and idiopathic pulmonary fibrosis (22-24) and it 
had been shown that activated alveolar macrophages 
were capable of producing FN (25). Therefore, the 
observation of elevated levels of FN in a good 
proportion of subjects in this study may suggest 
that the expanded numbers of inflammatory cells 
especially alveolar macrophages are activated. 
Fibronectin along with other mediators had been 
shown to contribute to the development of fibrosis by 
acting as a chemoattractant to fibroblasts in inter- 
stitial lung diseases (11,25). Therefore, the findings of 
elevated levels of FN in BAL fluid with macrophage- 
neutrophilic alveolitis may suggest that some of these 
patients may develop lung fibrosis. This has been 
further corroborated by the observation that three of 
five non-smoking subjects who had elevated FN 
levels at any one point of time had a decline in 
pulmonary function. In conformity with this, pul- 
monary fibrosis had been demonstrated by com- 
puterized tomography (CT) in a toxic gas exposed 
victim (26) and in experimental animals exposed to 
methyl isocyanate (27). 
As some of the patients exposed to toxic gas at 
Bhopal are having persistent respiratory symptoms, 
roentgenographic abnormalities and ventilatory 
defects as evidenced by significantly reduced pul- 
monary function values even 5 yr after exposure, the 
persisting alveolitis may result in further functional 
lung derangements that may lead to respiratory 
crippling. Therefore preventive and rehabilitative 
modalities of treatment for suppression of alveolitis 
are needed in this population. 
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